1
The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products.
2
Gland Pharma develops and manufactures generic injectables primarily for the U.S. market, and also for India and other semi-regulated markets.
3
A raft of patent expiries that will stretch until 2016 is expected to drive growth in the global generic injectables market.
4
Established in 1978, Gland Pharma develops and manufactures generic injectables primarily for the US market besides for India and other semi-regulated markets.
5
Gland Pharma develops and manufactures generic injectables primarily for selling in the U.S. market and also for India and some other markets.
6
Gland Pharma, based in the southern Indian city of Hyderabad, develops and manufactures generic injectables, primarily to sell in the United States and India.
7
Generic injectables are largely seen as interchangeable, so hospitals shop by price, not brand.